Croissance Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Nagpur, Maharashtra, India, established in 2014.
2014 Nagpur, Maharashtra, India Struck Off
Last Updated:
Access Report
About Croissance Drugs Private Limited

Croissance Drugs Private Limited, a struck off private limited company, was established on 28 January 2014 in Nagpur, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2014PTC252512. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.

Its leadership includes Meenakshi Ajay Shinde (Director), Chanderlal Diwanmal Jhambia (Director), Chaitali Gantgadhar Wankhede (Director). Past directors included Meenakshi Ajay Shinde, Amrish Vilas Bukkawar, Vaishali Sagar Mankar. It is based at Shop No 4, Second Floor B R Complex, Tawakkal Layout, Wadi, Nagpur, Maharashtra, 440023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2014PTC252512

  • Registration Number

    252512

  • Incorporation Date

    28 January 2014

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 12 Year, 22 Days
Company report

Croissance Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Croissance Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Croissance Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Meenakshi Ajay Shinde Director 28 Jan 2014 Current
Chanderlal Diwanmal Jhambia Director 28 Oct 2015 Current
Chaitali Gantgadhar Wankhede Director 09 Oct 2015 Current
Vishal Chanderlal Jhambia Director 28 Oct 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Sep 2017 Past
Pramod Abcsdd Director 19 Sep 2017 Past
Pramod Abcsdd Director 07 Jul 2014 Past
Pramod Abcsdd Director 29 Sep 2017 Past
Pramod Abcsdd Director 19 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Croissance Drugs.

Enhance accessibility to Croissance Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Croissance Drugs revenue growth over time
Croissance Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Croissance Drugs?

Unlock access to Croissance Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Croissance Drugs?

Unlock and access historical data on people associated with Croissance Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Croissance Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Croissance Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Croissance Drugs
Recent Activity within the Organization
  • Director Appointment

    Chanderlal Diwanmal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 10 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Vishal Chanderlal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 10 years 3 months . was completed.

  • Director Appointment

    Progress on Chaitali Gantgadhar Wankhede was appointed as a Director was appointed as a Director on 09 Oct 2015 & has been associated with this company since 10 years 4 months . was documented.

  • Director Appointment

    The activity Meenakshi Ajay Shinde was appointed as a Director was appointed as a Director on 28 Jan 2014 & has been associated with this company since 12 years 22 days . was completed.

  • Company Incorporation

    Progress on Croissance Drugs Private Limited was registered on 28 Jan 2014 with Roc Mumbai & aged 12 years 22 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Croissance Drugs Private Limited?

The CIN of Croissance Drugs Private Limited is U24100MH2014PTC252512.

Where is Croissance Drugs Private Limited headquartered?

Croissance Drugs Private Limited is headquartered at Shop No 4, Second Floor B R Complex, Tawakkal Layout, Wadi, Nagpur, Maharashtra, 440023.

When was Croissance Drugs Private Limited incorporated?

Croissance Drugs Private Limited was incorporated on 28 January 2014.

Who are the current directors of Croissance Drugs Private Limited?

The current directors of Croissance Drugs Private Limited are

What is the primary industry of Croissance Drugs Private Limited?

The primary industry of Croissance Drugs Private Limited is Chemicals.

Is Croissance Drugs Private Limited a listed company?

Croissance Drugs Private Limited is unlisted.

What is the capital structure of Croissance Drugs Private Limited?

The authorized capital of Croissance Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available